Anika Therapeutics, Inc. cotiza a 20.47 USD y tiene una capitalización bursátil de $274M. En los últimos 12 meses ha facturado $121M con un margen de flujo de caja libre del 3.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement pro…
| Periodo | 2026-11 | 2026-07 | 2026-04 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.42 | $0.27 | $0.31 |
| Estimado | $0.42 | $0.03 | — | $0.02 |
| Sorpresa | — | +1300.0% | — | +1450.0% |
| Métrica | ANIK | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 56.6% | 57.0% | -0.5% |
| Operating Margin | -9.8% | -38.6% | +28.8% |
| Net Margin | -9.6% | -33.6% | +23.9% |
| FCF Margin | 3.9% | -13.9% | +17.7% |
| ROE | -7.6% | -40.4% | +32.8% |
| ROA | -5.7% | -32.0% | +26.3% |
| Current Ratio | 4.72 | 2.84 | +1.88 |
| Debt / Equity | — | 0.28 | — |